First-in-human novel valveless artificial heart implanted in a patient with end-stage heart failure as a bridge to heart transplant   Houston, Texas, July 25, 2024 – The Texas Heart Institute (THI) and BiVACOR®, a clinical-stage medical device company, announced today the successful first-in-human implantation of the BiVACOR Total Artificial Heart (TAH) as part of the … Continue reading The Texas Heart Institute Implants BiVACOR® Total Artificial Heart